Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 6869969 Estrogen receptor modulators

Patent 6869969 was granted and assigned to Chiron Corporation on March, 2005 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

Chiron Corporation

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Rob Trainor0

Thayalan Navaratnam0

Verena D. Huebner0

Xiaodong Lin0

Liang Wang0

Beata Krywult0

Ian James0

Jennifer C. Moore0

...

Date of Patent

March 22, 2005

0

Patent Application Number

107136210

Date Filed

November 13, 2003

0

Patent Citations Received

US Patent 11865179 Progesterone formulations having a desirable PK profile

0

Patent Primary Examiner

Deborah C. Lambkin

0

Patent abstract

Isoxazole estrogen receptor agonist and antagonist compounds having unexpected and surprising activity in modulating estrogen receptor activity are described. In addition, methods and compositions for treating or preventing estrogen receptor-mediated disorders are disclosed. The compounds, methods, and compositions of the invention have utility in preventing or treating estrogen receptor-mediated disorders such as osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer's disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 6869969 Estrogen receptor modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.